ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
CalciMedica Inc

CalciMedica Inc (CALC)

3.19
-0.03
(-0.93%)
Closed January 06 3:00PM
3.19
0.00
(0.00%)
After Hours: 3:30PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
3.19
Bid
3.19
Ask
3.69
Volume
10,826
3.245 Day's Range 3.4399
2.05 52 Week Range 8.38
Market Cap
Previous Close
3.22
Open
3.29
Last Trade
1115
@
3.19
Last Trade Time
Financial Volume
US$ 35,964
VWAP
3.322
Average Volume (3m)
65,332
Shares Outstanding
13,481,917
Dividend Yield
-
PE Ratio
-2.16
Earnings Per Share (EPS)
-2.55
Revenue
-
Net Profit
-34.36M

About CalciMedica Inc

CalciMedica, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies for life-threatening inflammatory diseases with high unmet needs. Its technology targets the inhibition of Calcium Release-Activated Calcium (CRAC) channels designed to modulate the immune... CalciMedica, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies for life-threatening inflammatory diseases with high unmet needs. Its technology targets the inhibition of Calcium Release-Activated Calcium (CRAC) channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases. CRAC channels serve to replenish calcium levels in the endoplasmic reticulum (ER) and provide calcium for cellular signaling events. Its lead product candidate, Auxora, is an intravenous-formulated, small molecule CRAC channel inhibitor. Auxora has the capability to modulate the immune response and protect against tissue cell injury, addressing inflammatory diseases, such as acute pancreatitis (AP), asparaginase-associated acute pancreatitis (AAP), acute kidney injury (AKI), and acute hypoxemic respiratory failure. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-
CalciMedica Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CALC. The last closing price for CalciMedica was US$3.22. Over the last year, CalciMedica shares have traded in a share price range of US$ 2.05 to US$ 8.38.

CalciMedica currently has 13,481,917 shares outstanding. The market capitalization of CalciMedica is US$43.41 million. CalciMedica has a price to earnings ratio (PE ratio) of -2.16.

CALC Latest News

CalciMedica to Participate in the Piper Sandler 36th Annual Healthcare Conference

CalciMedica to Participate in the Piper Sandler 36th Annual Healthcare Conference PR Newswire LA JOLLA, Calif., Nov. 21, 2024 LA JOLLA, Calif., Nov. 21, 2024 /PRNewswire/ -- CalciMedica Inc...

CalciMedica Announces Presentations at Upcoming Medical Meetings

CalciMedica Announces Presentations at Upcoming Medical Meetings PR Newswire LA JOLLA, Calif., Nov. 20, 2024 Prof. Robert Sutton to deliver plenary presentation on Phase 2b CARPO trial of Auxora™...

CalciMedica Reports Third Quarter 2024 Financial Results and Provides Clinical & Corporate Updates

CalciMedica Reports Third Quarter 2024 Financial Results and Provides Clinical & Corporate Updates PR Newswire LA JOLLA, Calif., Nov. 13, 2024 Additional positive data, including a win ratio...

CalciMedica Strengthens Leadership Team with Appointment of Stephen Bardin as Chief Financial Officer

CalciMedica Strengthens Leadership Team with Appointment of Stephen Bardin as Chief Financial Officer PR Newswire LA JOLLA, Calif., Nov. 7, 2024 LA JOLLA, Calif., Nov. 7, 2024 /PRNewswire/...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.3411.92982456142.853.672.67506593.42368487CS
40.279.246575342472.923.672.55485122.94054431CS
12-0.7-17.99485861183.895.652.05653323.3878076CS
26-1.13-26.15740740744.325.972.05495493.85409534CS
52-0.31-8.857142857143.58.382.05386914.08596737CS
156-13.19-80.52503052516.3816.381.17165023.97701809CS
260-13.19-80.52503052516.3816.381.17116393.97701809CS

CALC - Frequently Asked Questions (FAQ)

What is the current CalciMedica share price?
The current share price of CalciMedica is US$ 3.19
How many CalciMedica shares are in issue?
CalciMedica has 13,481,917 shares in issue
What is the market cap of CalciMedica?
The market capitalisation of CalciMedica is USD 43.41M
What is the 1 year trading range for CalciMedica share price?
CalciMedica has traded in the range of US$ 2.05 to US$ 8.38 during the past year
What is the PE ratio of CalciMedica?
The price to earnings ratio of CalciMedica is -2.16
What is the reporting currency for CalciMedica?
CalciMedica reports financial results in USD
What is the latest annual profit for CalciMedica?
The latest annual profit of CalciMedica is USD -34.36M
What is the registered address of CalciMedica?
The registered address for CalciMedica is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the CalciMedica website address?
The website address for CalciMedica is www.calcimedica.com
Which industry sector does CalciMedica operate in?
CalciMedica operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BOXLBoxlight Corporation
US$ 1.645
(257.61%)
240.37M
SPRCSciSparc Ltd
US$ 1.06
(100.80%)
189.16M
XTIAXTI Aerospace Inc
US$ 0.08261
(99.54%)
1.55B
DHAIDIH Holdings US Inc
US$ 2.8602
(82.18%)
4.63M
NXPLNextPlat Corporation
US$ 1.73
(61.68%)
12.6M
RGFReal Good Food Company Inc
US$ 1.31
(-63.49%)
1.47M
LUNALuna Innovations Incorporated
US$ 0.8744
(-57.35%)
12.29M
GCTKGlucoTrack Inc
US$ 0.1594
(-45.65%)
35.76M
ACONAclarion Inc
US$ 0.1699
(-43.06%)
35.05M
BLRXBioLineRx Ltd
US$ 0.1621
(-40.80%)
44.6M
XTIAXTI Aerospace Inc
US$ 0.08261
(99.54%)
1.56B
NVDANVIDIA Corporation
US$ 149.43
(3.43%)
264.32M
CNSPCNS Pharmaceuticals Inc
US$ 0.11987
(-2.54%)
246.67M
BOXLBoxlight Corporation
US$ 1.645
(257.61%)
240.38M
SPRCSciSparc Ltd
US$ 1.06
(100.80%)
190.41M

Your Recent History

Delayed Upgrade Clock